Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcadia Biosciences (RKDA) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to $884000.0.

  • Arcadia Biosciences' Cost of Revenue fell 1434.11% to $884000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year increase of 3902.33%. This contributed to the annual value of $3.0 million for FY2024, which is 3629.25% up from last year.
  • As of Q3 2025, Arcadia Biosciences' Cost of Revenue stood at $884000.0, which was down 1434.11% from $824000.0 recorded in Q2 2025.
  • In the past 5 years, Arcadia Biosciences' Cost of Revenue ranged from a high of $3.8 million in Q4 2021 and a low of $178000.0 during Q4 2023
  • Moreover, its 5-year median value for Cost of Revenue was $856000.0 (2021), whereas its average is $1.3 million.
  • Per our database at Business Quant, Arcadia Biosciences' Cost of Revenue surged by 54848.48% in 2021 and then tumbled by 8114.3% in 2023.
  • Over the past 5 years, Arcadia Biosciences' Cost of Revenue (Quarter) stood at $3.8 million in 2021, then tumbled by 76.03% to $900000.0 in 2022, then plummeted by 80.22% to $178000.0 in 2023, then skyrocketed by 364.61% to $827000.0 in 2024, then rose by 6.89% to $884000.0 in 2025.
  • Its Cost of Revenue was $884000.0 in Q3 2025, compared to $824000.0 in Q2 2025 and $682000.0 in Q1 2025.